Aclaris Therapeutics (ACRS) Interest & Investment Income (2014 - 2026)
Aclaris Therapeutics' Interest & Investment Income came in at $1.76 million for Q2 2026, down 12.7% from $2.02 million a year earlier but up 16.3% from the prior quarter.
Powered by 
Analysis
Aclaris Therapeutics (ACRS) Interest & Investment Income (2014 - 2026) Analysis & Trends
Over the trailing twelve months to Jun 30, 2026, Aclaris Therapeutics reported Interest & Investment Income of $6.73 million, down 18.7% year-over-year; for FY2025, it came in at $7.64 million, down 4.0% from FY2024.
- Going back by year, Interest & Investment Income was $7.95 million in FY2024 (-6.5%) and $8.51 million in FY2023.
- The five-year range for quarterly Interest & Investment Income is $1.51 million (Q1 2026) to $2.32 million (Q3 2023).
- Year-over-year, Interest & Investment Income has declined for four consecutive quarters, with an average decline of 9.4% over the last eight quarters.
- The fastest year-over-year change in Interest & Investment Income over five years came in Q1 2025 (growth of 8.8%), and the weakest in Q1 2026 (a decline of 30.1%).
- Business Quant data shows ACRS's Interest & Investment Income at $1.51 million (Q1 2026), $1.63 million (Q4 2025) and $1.82 million (Q3 2025) in the three quarters before Q2 2026.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Int & Inv Inc (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | - |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 219.00 Mn |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | - |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | - |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | - |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 80.00 Mn |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | - |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | - |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | - |
| 10 | Aclaris Therapeutics | 613.83 Mn | 613.83 Mn | 1.41 Mn | 1.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 1.76 Mn |
| Mar 31, 2026 | 1.51 Mn |
| Dec 31, 2025 | 1.63 Mn |
| Sep 30, 2025 | 1.82 Mn |
| Jun 30, 2025 | 2.02 Mn |
| Mar 31, 2025 | 2.17 Mn |
| Dec 31, 2024 | 2.10 Mn |
| Sep 30, 2024 | 1.99 Mn |
| Jun 30, 2024 | 1.87 Mn |
| Mar 31, 2024 | 1.99 Mn |
| Dec 31, 2023 | 2.19 Mn |
| Sep 30, 2023 | 2.32 Mn |
| Dec 31, 2015 | 89,000.00 |
| Sep 30, 2015 | 7,000.00 |
| Jun 30, 2015 | 2,000.00 |
| Mar 31, 2015 | 6,000.00 |
| Dec 31, 2014 | 5,000.00 |
| Sep 30, 2014 | 5,000.00 |
API Access
Aclaris Therapeutics Interest & Investment Income API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ACRS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "interest-and-investment-income", "ticker": "ACRS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=interest-and-investment-income&ticker=ACRS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();